139 related articles for article (PubMed ID: 16095502)
21. Successful treatment of unresectable advanced hepatoblastoma: living liver transplantation after surgical removal of lung metastasis.
Miyamura T; Yoshida R; Yagi T; Matsukawa H; Chayama K; Ishida T; Washio K; Morishita N; Oda M; Morishima T
Pediatr Transplant; 2011 Aug; 15(5):E87-91. PubMed ID: 20070564
[TBL] [Abstract][Full Text] [Related]
22. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
Katzenstein HM; Langham MR; Malogolowkin MH; Krailo MD; Towbin AJ; McCarville MB; Finegold MJ; Ranganathan S; Dunn S; McGahren ED; Tiao GM; O'Neill AF; Qayed M; Furman WL; Xia C; Rodriguez-Galindo C; Meyers RL
Lancet Oncol; 2019 May; 20(5):719-727. PubMed ID: 30975630
[TBL] [Abstract][Full Text] [Related]
23. Successful liver transplant for unresectable hepatoblastoma.
Casas-Melley AT; Malatack J; Consolini D; Mann K; Raab C; Flynn L; Woolfrey P; Menendez J; Dunn SP
J Pediatr Surg; 2007 Jan; 42(1):184-7. PubMed ID: 17208562
[TBL] [Abstract][Full Text] [Related]
24. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma.
Carceller A; Blanchard H; Champagne J; St-Vil D; Bensoussan AL
J Pediatr Surg; 2001 May; 36(5):755-9. PubMed ID: 11329582
[TBL] [Abstract][Full Text] [Related]
25. Pretransplant trends in α-fetoprotein levels as a predictor of recurrence after living donor liver transplantation for unresectable hepatoblastoma: A single-institution experience.
Isono K; Ohya Y; Lee KJ; Hashimoto S; Kadohisa M; Sakisaka M; Uto K; Hayashida S; Yamamoto H; Yamamoto H; Sugawara Y; Inomata Y
Pediatr Transplant; 2018 Aug; 22(5):e13221. PubMed ID: 29761829
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
[TBL] [Abstract][Full Text] [Related]
27. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
[TBL] [Abstract][Full Text] [Related]
28. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
Sunil BJ; Palaniappan R; Venkitaraman B; Ranganathan R
J Gastrointest Cancer; 2018 Dec; 49(4):493-496. PubMed ID: 28963691
[TBL] [Abstract][Full Text] [Related]
29. Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.
Ismail H; Broniszczak D; Kaliciński P; Dembowska-Bagińska B; Perek D; Teisseyre J; Kluge P; Kościesza A; Lembas A; Markiewicz M
J Pediatr Surg; 2012 Jul; 47(7):1331-9. PubMed ID: 22813792
[TBL] [Abstract][Full Text] [Related]
30. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
Zsiros J; Brugieres L; Brock P; Roebuck D; Maibach R; Zimmermann A; Childs M; Pariente D; Laithier V; Otte JB; Branchereau S; Aronson D; Rangaswami A; Ronghe M; Casanova M; Sullivan M; Morland B; Czauderna P; Perilongo G;
Lancet Oncol; 2013 Aug; 14(9):834-42. PubMed ID: 23831416
[TBL] [Abstract][Full Text] [Related]
31. Orthotopic liver transplantation for unresectable hepatoblastoma.
Srinivasan P; McCall J; Pritchard J; Dhawan A; Baker A; Vergani GM; Muiesan P; Rela M; David Heaton N
Transplantation; 2002 Sep; 74(5):652-5. PubMed ID: 12352881
[TBL] [Abstract][Full Text] [Related]
32. Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
Koh KN; Park M; Kim BE; Bae KW; Kim KM; Im HJ; Seo JJ
Pediatr Blood Cancer; 2011 Oct; 57(4):554-60. PubMed ID: 21370433
[TBL] [Abstract][Full Text] [Related]
33. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy and prognosis factors for advanced hepatoblastoma in children: a 6-year retrospective study.
Zhang Y; Zhang WL; Huang DS; Hong L; Wang YZ; Zhu X; Hu HM; Zhang PW; Yi Y; Han T
Asian Pac J Cancer Prev; 2013; 14(8):4583-9. PubMed ID: 24083706
[TBL] [Abstract][Full Text] [Related]
35. Successful autologous peripheral blood stem cell transplantation with a double-conditioning regimen for recurrent hepatoblastoma after liver transplantation.
Niwa A; Umeda K; Awaya T; Yui Y; Matsubara H; Hiramatsu H; Watanabe K; Adachi S; Itoh T; Uemoto S; Nakahata T
Pediatr Transplant; 2009 Mar; 13(2):259-62. PubMed ID: 18444949
[TBL] [Abstract][Full Text] [Related]
36. Extreme hepatic resections for the treatment of advanced hepatoblastoma: Are planned close margins an acceptable approach?
Fonseca A; Gupta A; Shaikh F; Ramphal R; Ng V; McGilvray I; Gerstle JT
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921939
[TBL] [Abstract][Full Text] [Related]
37. Recent improvement in survival outcomes and reappraisal of prognostic factors in hepatoblastoma.
Koh KN; Namgoong JM; Yoon HM; Cho YA; Choi SH; Shin J; Kang SH; Suh JK; Kim H; Oh SH; Kim KM; Kim DY; Im HJ
Cancer Med; 2021 May; 10(10):3261-3273. PubMed ID: 33939313
[TBL] [Abstract][Full Text] [Related]
38. Is multifocality a prognostic factor in childhood hepatoblastoma?
Saettini F; Conter V; Provenzi M; Rota M; Giraldi E; Foglia C; Cavalleri L; D'Antiga L
Pediatr Blood Cancer; 2014 Sep; 61(9):1593-7. PubMed ID: 24757164
[TBL] [Abstract][Full Text] [Related]
39. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor.
Sasaki F; Matsunaga T; Iwafuchi M; Hayashi Y; Ohkawa H; Ohira M; Okamatsu T; Sugito T; Tsuchida Y; Toyosaka A; Nagahara N; Nishihira H; Hata Y; Uchino J; Misugi K; Ohnuma N;
J Pediatr Surg; 2002 Jun; 37(6):851-6. PubMed ID: 12037748
[TBL] [Abstract][Full Text] [Related]
40. Benefit of early inflow exclusion during living donor liver transplantation for unresectable hepatoblastoma.
Uchida H; Fukuda A; Sasaki K; Hirata Y; Shigeta T; Kanazawa H; Nakazawa A; Miyazaki O; Nosaka S; Mali VP; Sakamoto S; Kasahara M
J Pediatr Surg; 2016 Nov; 51(11):1807-1811. PubMed ID: 27325360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]